ROLE OF MYCOBACTERIUM TUBERCULOSIS PROTEASE IN PATHOGENESIS AND HOST RESPONSE
ROLE OF MYCOBACTERIUM TUBERCULOSIS PROTEASE IN PATHOGENESIS AND HOST RESPONSE
批准号:
8172462
负责人:
Jyothi Rengarajan
金额:
$5.48万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-01 至 2011-04-30
关键词:
BiochemicalCleaved cellComputer Retrieval of Information on Scientific Projects DatabaseDiseaseFundingGenus MycobacteriumGoalsGrantGrowthHumanImmune responseImmunityInstitutionLungMolecularMusMycobacterium tuberculosisNatural ImmunityPathogenesisPathologyPeptide HydrolasesResearchResearch PersonnelResourcesRoleSourceTherapeutic InterventionTuberculosisUnited States National Institutes of HealthVaccine DesignVaccinesVirulence Factorsbasecell envelopedesignin vivoinsightmacrophagemicrobicidemutantpathogen
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Mycobacterium tuberculosis is a highly successful human pathogen that has evolved to survive within the host. Our long-term goals are to delineate the mechanisms by which M. tuberculosis interferes with the microbicidal functions of macrophages and evades host immune responses. Understanding the molecular mechanisms underlying M. tuberculosis-host interactions is important for designing therapeutic interventions and vaccine strategies. We have identified Rv2224c, a predicted protease, as being critical for survival in macrophages and in vivo.
We hypothesize that Rv2224c is an important virulence factor that proteolytically cleaves M. tuberculosis substrates and modulates the host immune response. While proteases are known to be key virulence factors in other bacterial pathogens, the function of proteases in M. tuberculosis pathogenesis has been largely unexplored.
Our preliminary studies indicate that Rv2224c is exported to the cell envelope of mycobacteria. A mutant disrupted in the protease is impaired for growth in macrophages and in vivo. Mice infected with a protease mutant show markedly reduced lung pathology and survive longer than wildtype-infected mice and we have new evidence that Rv2224c modulates host innate immunity.
In this project we are exploring the biochemical and molecular basis for protease function in M. tuberculosis, including characterizing a candidate substrate. We are also studying the role of protease in host-pathogen interactions. The specific aims are: 1. Biochemical characterization of Rv2224c and its potential substrate(s) in M. tuberculosis; 2. Study the immune response induced by Rv2224c in vivo; 3. Dissect the modulation of macrophage function by the protease.
Characterizing how Rv2224c modulates immune responses will provide insights into understanding how M. tuberculosis evades host immunity, and help in designing vaccines to protect against tuberculosis disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Innate-adaptive crosstalk in protective and vaccine-induced immunity to TB
-
批准号:9412338
-
项目类别:
-
资助金额:$62.94万
-
财政年份:2017
-
负责人:Jyothi Rengarajan
-
依托单位:
Targeting an immunomodulatory protease for adjunctive tuberculosis chemotherapy
-
批准号:8996134
-
项目类别:
-
资助金额:$22.76万
-
财政年份:2015
-
负责人:Jyothi Rengarajan
-
依托单位:
Fourth Southeastern Mycobacteria Meeting
-
批准号:8257389
-
项目类别:
-
资助金额:$0.4万
-
财政年份:2012
-
负责人:Jyothi Rengarajan
-
依托单位:
IMMUNE RESPONSES TO TUBERCULOSIS IN HIV POSITIVE AND HIV NEGATIVE INDIVIDUALS
-
批准号:8357494
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2011
-
负责人:Jyothi Rengarajan
-
依托单位:
MODULATION OF INNATE IMMUNE DEFENSES BY MYCOBACTERIUM TUBERCULOSIS
-
批准号:8357560
-
项目类别:
-
资助金额:$4.12万
-
财政年份:2011
-
负责人:Jyothi Rengarajan
-
依托单位:
ROLE OF MYCOBACTERIUM TUBERCULOSIS PROTEASE IN PATHOGENESIS AND HOST RESPONSE
-
批准号:8357499
-
项目类别:
-
资助金额:$4.12万
-
财政年份:2011
-
负责人:Jyothi Rengarajan
-
依托单位:
CELLULAR IMMUNE RESPONSES TO ACELLULAR PERTUSSIS VACCINATION IN INFANTS
-
批准号:8357559
-
项目类别:
-
资助金额:$4.12万
-
财政年份:2011
-
负责人:Jyothi Rengarajan
-
依托单位:
Modulation of Host Responses by Mycobacterium Tuberculosis
-
批准号:8259815
-
项目类别:
-
资助金额:$43.56万
-
财政年份:2010
-
负责人:Jyothi Rengarajan
-
依托单位:
Modulation of Host Responses by Mycobacterium Tuberculosis
-
批准号:8464378
-
项目类别:
-
资助金额:$40.95万
-
财政年份:2010
-
负责人:Jyothi Rengarajan
-
依托单位:
Modulation of Host Responses by Mycobacterium Tuberculosis
-
批准号:8065992
-
项目类别:
-
资助金额:$43.56万
-
财政年份:2010
-
负责人:Jyothi Rengarajan
-
依托单位:
Modulation of Host Responses by Mycobacterium Tuberculosis
-
批准号:7983071
-
项目类别:
-
资助金额:$44.0万
-
财政年份:2010
-
负责人:Jyothi Rengarajan
-
依托单位:
IMMUNE RESPONSES TO TUBERCULOSIS IN HIV POSITIVE AND HIV NEGATIVE INDIVIDUALS
-
批准号:8172456
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2010
-
负责人:Jyothi Rengarajan
-
依托单位:
Modulation of Host Responses by Mycobacterium Tuberculosis
-
批准号:8648983
-
项目类别:
-
资助金额:$43.56万
-
财政年份:2010
-
负责人:Jyothi Rengarajan
-
依托单位:
Modulation of Host Responses by Mycobacterium tuberculosis
-
批准号:9229666
-
项目类别:
-
资助金额:$54.15万
-
财政年份:2009
-
负责人:Jyothi Rengarajan
-
依托单位:
Role of Mycobacterium tuberculosis protease in pathogenesis and host response
-
批准号:7319922
-
项目类别:
-
资助金额:$1.04万
-
财政年份:2007
-
负责人:Jyothi Rengarajan
-
依托单位:
Role of Mycobacterium tuberculosis protease in pathogenesis and host response
-
批准号:7502359
-
项目类别:
-
资助金额:$7.96万
-
财政年份:2007
-
负责人:Jyothi Rengarajan
-
依托单位:
Role of Mycobacterium tuberculosis protease in pathogenesis and host response
-
批准号:7662473
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2007
-
负责人:Jyothi Rengarajan
-
依托单位:
Role of Mycobacterium tuberculosis protease in pathogenesis and host response
-
批准号:7891362
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2007
-
负责人:Jyothi Rengarajan
-
依托单位:
Role of Mycobacterium tuberculosis protease in pathogenesis and host response
-
批准号:7621168
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2007
-
负责人:Jyothi Rengarajan
-
依托单位:
Identification of human Mtb-specific T cell signatures that are associated
-
批准号:8909039
-
项目类别:
-
资助金额:$27.19万
-
财政年份:--
-
负责人:Jyothi Rengarajan
-
依托单位: